Andrew Duplessie is making his way in the industry as an actor, appearing in shows like "American Horror Story." But he is also an angel investor in cryptocurrency, working with VC companies to fund startups.
Duplessie sits down with Alyssa Julya Smith to discuss what he looks for in a crypto company and how he can tell when an entrepreneur has a good idea. He says he listens to pitches all day long, but at the end of the day, he really wants to see teamwork.
Duplessie sees the most growth in entrepreneurs who are looking to bring crypto to the average consumer. Finally, the investor describes how important sports are to blockchain and how the currency can make a difference in sports, both for players and fans.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
